YA, S., Gamal, M., EL-Nagar, E., S., K. (2020). The Immunogenicity and Protective Efficacy of DNA Vaccine Coding For NA1 Gene of Highly Pathogenic Avian Influenza H5N1 Subtype. Journal of Applied Veterinary Sciences, 5(2), 109-123. doi: 10.21608/javs.2020.85638
Soliman YA; Maha NA Gamal; Eman EL-Nagar; Khalil S.. "The Immunogenicity and Protective Efficacy of DNA Vaccine Coding For NA1 Gene of Highly Pathogenic Avian Influenza H5N1 Subtype". Journal of Applied Veterinary Sciences, 5, 2, 2020, 109-123. doi: 10.21608/javs.2020.85638
YA, S., Gamal, M., EL-Nagar, E., S., K. (2020). 'The Immunogenicity and Protective Efficacy of DNA Vaccine Coding For NA1 Gene of Highly Pathogenic Avian Influenza H5N1 Subtype', Journal of Applied Veterinary Sciences, 5(2), pp. 109-123. doi: 10.21608/javs.2020.85638
YA, S., Gamal, M., EL-Nagar, E., S., K. The Immunogenicity and Protective Efficacy of DNA Vaccine Coding For NA1 Gene of Highly Pathogenic Avian Influenza H5N1 Subtype. Journal of Applied Veterinary Sciences, 2020; 5(2): 109-123. doi: 10.21608/javs.2020.85638
The Immunogenicity and Protective Efficacy of DNA Vaccine Coding For NA1 Gene of Highly Pathogenic Avian Influenza H5N1 Subtype
1Central Laboratory for Evaluation of Veterinary Biologics ,Abbasiaa ,Cairo, Egypt.
2Central Laboratory for Evaluation of Veterinary Biologics, Abbasia ,Cairo, Egypt.
3Veterinary Serum and Vaccine Research Institute VSVRI , Abbasia Cairo, Egypt.
4Faculty of Vet. Med., Alexandria University, Alexandria, Egypt.
Receive Date: 06 April 2020,
Revise Date: 23 April 2020,
Accept Date: 25 April 2020
Abstract
Control of avian influenza infection depends mainly on biosafety measures and vaccination, DNA vaccination is a novel method to generate antigen-specific antibody and cell-mediated immunity. In the current study, a DNA vaccine for a full-length N1 gene was developed in a trial to decrease the severity of the avian influenza virus spread and shedding. THE full-length N1 gene was cloned in entry clone p < /em>ENTER SD/TOPO, followed by homologous recombination with the destination mammalian expression vector (PDEST 40). The PDEST 40-N1 was used in the immunization of SPF chickens. Potency was evaluated through the survival rate that reaches 65%, which was far less than the commercially available inactivated vaccine. Meanwhile, the shedding of the virus from dead birds was 0.46 Log 10 EID50. At the same time, the most surprising result was the shedding level of the vaccinated live birds that were zero sheddings;on the other hand, the inactivated vaccine could not reduce the shedding level which remains very high (3.2 Log 10 EID50 ). IFN-γ transcript level in the DNA vaccinated group was detected by the 3rd-day post-vaccination and remained upregulated till the 28th post-vaccination. After the challenge, the level of IFN-γ was much higher until 14 days post-challenge. The inactivated vaccine could not stimulate any detectable level post-vaccination. These data suggested the ability of DNA vaccine coding for N1 gene of avian influenza to combat the virus shedding from live birds and could be used in combination with DNA vaccine coding for H5 to produce maximum protection with zero sheddings.
BARMAN S, ADHIKARY L, CHAKRABARTI AK, BERNAS C, KAWAOKA Y AND NAYAK DP.2004. Role of Transmembrane Domain and Cytoplasmic Tail Amino Acid Sequences of Influenza A Virus Neuraminidase in Raft Association and Virus Budding Journal of Virology 78(10):5258-69
BLUMENKRANTZ D, KIM L, ROBERTS HS, SAMANTHA L, BARCLAY WS. 2013. The Short Stalk Length of Highly Pathogenic Avian Influenza H5N1 Virus Neuraminidase Limits Transmission of Pandemic H1N1 Virus in Ferrets. Journal of Virology (87) p. 10539 –10551
BOSHART M, WEBER F, JAHN G, DORSCH-HÄSLER K, FLECKENSTEIN B AND SCHAFFNER W.1985. A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus. Cell. 41(2):521-530
CAPUA I AND ALEXANDER DJ.2007. Avian influenza: recent development.Avian pathol, 33(4):393-404.
CAPUA I AND MARANGON S. 2007. Control and prevention of avian influenza in an evolving scenario.Vaccine. 26(30):5645-5652
CHEN YQ, WOHLBOLD TJ, ZHENG NY, HUANG M, HUANG Y, NEU KE, ET AL.2018. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell. 173:417–29 e10. doi: 10.1016/j.cell.2018.03.030
EMAN MS EL-NAGAR. 2014. Study of the immunopotentiation effect of Esat-6 of Mycobacteria on DNA vaccine encoding the H5 gene of avian influenza virus. PhD thesis, Vet. Collage, Cairo University.
FLYNN KJ ET AL. 1999. In vivo proliferation of naive and memory influenza-specific CD8 (+) T cells. Proc Natl Acad Sci USA 96(15):8597–8602
FOUCHIER R, MUNSTER VA, WALLENSTEN T, BESTEBROER S, HERFST D, SMITH G, RIMMELZWAAN B, OLSEN A AND OSTERHAUS .2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls, J. Virol. 79 2814–2822
GUO H, KUMAR P AND MALARKANNAN S .2011. Evasion of natural killer cells by influenza virus. J Leukoc Biol. 2011 Feb; 89(2): 189–194
PADILLA-QUIRARTE HO, DELIA V. LOPEZ-GUERRERO, LOURDES GUTIERREZ-XICOTENCATL AND FERNANDO ESQUIVEL-GUADARRAMA1.2019.Protective Antibodies against Influenza Proteins. Front. Immunol., 18 2019 | https://doi.org/10.3389/fimmu.2019.01677
HARRIS KA, FREIDL G S, MUNOZ O S, VON DOBSCHUETZ S, DE NARDI M AND WIELAND B, ET AL. 2017. Epidemiological risk factors for animal influenza A viruses overcoming species barriers. EcoHealth 14, 342–360.
HONG YH, LILLEHOJ HS, LILLEHOJ EP AND LEE SH. 2006. Changes in immune-related gene expression and intestinal lymphocyte subpopulations following Eimeria maxima infection of chickens. Vet. Immunol. Immunopathol. 114(3-4): 259-272.
HSU SM, CHEN TH AND WANG CH .2010. Efficacy of Avian Influenza Vaccine in Poultry: A Meta-analysis. Avian Diseases: 54, (4), 1197-1209
JALILIAN B, ABDUL RAHMAN OMAR, BEJO MH, ALITHEEN NB, RASOLI M AND SOHKICHI MATSUMOTO .2010. Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant Genet Vaccines Ther. , 8: 4
KAISER P, UNDERWOOD G AND DAVISON F. 2003. Differential Cytokine Responses following Marek’s Disease Virus Infection of Chickens Differing in Resistance to Marek’s Disease. J. of Virol. 77. (1): 762–768
KIM C, LEW W, WILLIAMS M, LIU H, ZHANG L, SWAMINATHAN S, BISCHOFBERGER N, CHEN M, MENDEL D, TAI C, LAVER W AND STEVENS R. 1997. Influenza neuraminidase inhibitors are possessing a novel hydrophobic interaction in the enzyme active site. Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity, J. Am. Chem. Soc. 119:681–690.
LEITNER WW, SEGUIN MC BALLOU WR, SEITZ JP, SCHULTZ AM, SHEEHY MJ AND LYON JA .1997. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J Immunol.159:6112-6119
LIMA KM, SANTOS SA, LIMA VMF, COELHO-CASTELO AAM, RODRIGUES JM AND SILVA CL.2003. Single dose of a vaccine based on DNA encoding mycobacterial HSP65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Therapy.; 10(8):678–685. doi: 10.1038/sj.gt.3301908
MAHA AN GAMAL. 2016. Production and Evaluation of DNA vaccine coding for Neuraminidase N1 gene against avian influenza H5N1. PhD thesis, Vet. Faculty, Alexandria University.
MARCELIN G, SANDBULTE M AND WEBBEY .2012. Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines. Reviews in Medical Virology 22(4):267-79 ·
MATROSOVICH MN ET AL. 2004. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78(22):12665–12667
MCAULEY JL, GILBERTSON BP, TRIFKOVIC S, BROWN LE AND MCKIMM-BRESCHKIN JL. 2019. Influenza Virus Neuraminidase Structure and Functions. Front Microbiol. 10: 39
MEMOLI MJ, SHAW PA, HAN A, CZAJKOWSKI L, REED S, ATHOTA R, ET AL.2016. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model. MBio. 7:e00417–16. doi: 10.1128/mBio.00417-16
NAKSUPAN N,SANGUANSERMSRI D, WONGVILAIRAT R, NIUMSUP P, PONGCHAROEN S,CHAMNANPOOD P, CHAMNANPOOD C AND SANGUANSERMSRI P. 2008. Whole-genome sequences of h5n1 influenza A virus isolated from a little grebe in Thailand. Southeast Asian J. Trop Med Public Health, 39 (3): 373- 382
NAYAK B, KUMAR S, DINAPOLI JM, PALDURAI A, PEREZ DR, COLLINS PL AND SAMAL SK. 2010. Contributions of the Avian Influenza Virus HA, NA, and M2 Surface Proteins to the Induction of Neutralizing Antibodies and Protective Immunity. J Virol. 84(5): 2408–2420
NELSON J A, REYNOLDS-KOHLER C, AND SMITH BA. 1987. Negative and Positive Regulation by a Short Segment in the 5´-Flanking Region of the Human Cytomegalovirus Major Immediate-Early Gene. Molec. Cell. Biol. 7: 4125-4129.
PETE K, GREG U.AND FRED, DAVISON .2003. Differential Cytokine Responses following Marek’s Disease Virus Infection of Chickens Differing in Resistance to Marek’s Disease J. Virol, 77, (1): 762–768
REED LJ AND MUENCH H. 1938. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology, 27, (3): 493–497.
SAMBROOK J, FRITSCHEF AND MANIATIS T. 1989. Molecular cloning: A laboratory manual, 2nd ed.Cold Spring Harbor Lab., N.Y.
SCHMITTGEN TD AND LIVAK KJ. 2008. Analyzing real-time PCR data by the comparative Ct method. Nature Prot. 3:1101-1108.
SOLIMAN YA, MAHA A GAMAL AND KHALIL SA .2016. Generation of Plasmid Vector Coding for Neuraminidase Gene NA1 of Highly Pathogenic Avian Influenza H5N1 Subtype. Alexandria Journal of Veterinary Sciences; 51(2): 101-111
SOUTHERN P J, AND BERG P. 1982. Transformation of Mammalian Cells to Antibiotic Resistance with a Bacterial Gene under Control of the SV40 Early Region Promoter. J. Molec. Appl. Gen. 1:327-339.
SYLTE MJ AND SUAREZ DL.2009. Influenza Neuraminidase as a Vaccine Antigen Curr Top Microbiol Immunol. 333:227-41
TONG S, ZHU X, LI Y,SHI M, ZHANG J AND BOURGEOIS M ET AL. 2013. New world bats harbour diverse influenza A viruses. PLoS Pathog. 9. E1003657
VAN DE SANDT C E, KREIJTZ J H AND RIMMELZWAAN G F. 2012. Evasion of influenza A viruses from innate and adaptive immune responses. Viruses. 4(9):1438-76.
WEBSTER R, BEAN W, GORMAN O, CHAMBERS T AND KAWAOKA Y. 1992. Evolution and ecology of influenza A viruses, Microbiol. Rev. 56 () 152–179.
WILEY JA ET AL. 2001. Antigen-specific CD8 (+) T cells persist in the upper respiratory tract following influenza virus infection. J Immunol 167(6):3293–3299
YEONG HH, HYUN SL, SUNG HL, RAM AD AND ERIK PL. 2014. Analysis of chicken cytokine and chemokine gene expression following Eimeria acervulina and Eimeria tenella infections. Veterinary Immunology and Immunopathology 114: 209–223
View on SCiNiTO
Top